Volume 61, Issue 1, Pages (July 2014)

Slides:

Advertisements

Similar presentations

EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep

Advertisements

Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.

Global gene repression in hepatocellular carcinoma and fetal liver, and suppression of dudulin-2 mRNA as a possible marker for the cirrhosis-to-tumor transition.

Volume 63, Issue 1, Pages (July 2015)

Volume 53, Issue 1, Pages (July 2010)

Volume 46, Issue 3, Pages (March 2007)

Volume 59, Issue 1, Pages (July 2013)

The clinical features and management of women with ductal carcinoma in situ with microinvasion: A retrospective Cohort study Ying Li, Sheng Zhang, Xi.

Kirsten Boonstra, Ulrich Beuers, Cyriel Y. Ponsioen

Inflammasomes in liver diseases

Volume 67, Issue 2, Pages (August 2017)

Volume 50, Issue 4, Pages (April 2009)

MELD: the holy grail of organ allocation?

Radioembolization for hepatocellular carcinoma

Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review Christian Thoma, Christopher P. Day, Michael.

MELD score is a better prognostic model than Child-Turcotte-Pugh score or Discriminant Function score in patients with alcoholic hepatitis Wichit Srikureja,

Volume 25, Issue 4, Pages (April 2014)

Volume 61, Issue 6, Pages (December 2014)

Reactive oxygen species in the normal and acutely injured liver

Matthew T. Kitson, Stuart K. Roberts Journal of Hepatology

The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.

A Cross-sectional Study on the Symptom Burden of Patients With Spinal Tumor: Validation of the Chinese Version of the M.D. Anderson Symptom Inventory—Spine.

Immigration and viral hepatitis

Comparison of Patterns and Outcomes of Liver Resection for Hepatocellular Carcinoma: East vs West Tian Yang, Parissa Tabrizian, Han Zhang, Wan-Yee Lau,

Volume 66, Issue 1, Pages 1-4 (January 2017)

Living donor liver transplantation: is the hype over?

The place of downstaging for hepatocellular carcinoma

Volume 58, Issue 3, Pages (March 2013)

Reply to: “Low free T3 levels are related to early mortality in patients with decompensated cirrhosis and acute-on chronic liver failure” Rakhi Maiwall,

ART score for retreatment with transarterial chemoembolization in patients with hepatocellular carcinoma: Is it really applicable? Jian Wu, Wei Bai,

Cheng-Yuan Peng, Rong-Nan Chien, Yun-Fan Liaw Journal of Hepatology

Volume 65, Issue 4, Pages (October 2016)

European Association for the Study of the Liver Journal of Hepatology

Volume 68, Issue 1, Pages (January 2018)

Hepatitis C core protein – The “core” of immune deception?

Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study Gyuri Kim, Suk-Yong Jang, Chung.

Volume 62, Issue 3, Pages (March 2015)

Radioembolization for hepatocellular carcinoma

Genomic risk of hepatitis C-related hepatocellular carcinoma

Autophagy in the liver Journal of Hepatology

Volume 66, Issue 2, Pages (February 2017)

Behzad Hajarizadeh, Jason Grebely, Gregory J. Dore

EASL Clinical Practice Guidelines: Wilson’s disease

Roberto de Franchis, Aleksander Krag Journal of Hepatology

Wolfgang Sieghart, Florian Hucke, Markus Peck-Radosavljevic

Volume 57, Issue 5, Pages (November 2012)

Volume 50, Issue 4, Pages (April 2009)

Antiviral therapy for chronic hepatitis B: Challenges in Hong Kong

Chetana Lim, Chady Salloum, Daniel Azoulay

Immigration and viral hepatitis

Evolution of liver transplantation for hepatocellular carcinoma

The potential of induced pluripotent stem cell derived hepatocytes

Global burden of alcoholic liver diseases

HCV targeting of patients with cirrhosis

Combined locoregional-immunotherapy for liver cancer

Volume 63, Issue 1, Pages (July 2015)

The use of hemospray in portal hypertensive bleeding; a case series

Volume 66, Issue 3, Pages (March 2017)

Volume 49, Issue 1, Pages (July 2008)

Integrating sorafenib into an algorithm for the management of post-transplant hepatocellular carcinoma recurrence Christian Toso, Gilles Mentha, Pietro.

Volume 70, Issue 4, Pages (April 2019)

New trials and results in systemic treatment of HCC

Liver transplantation in children

Reply to: “Flow cytometry makes all the difference”

Pathogenesis of cholestatic hepatitis C

Chimeric mouse model of hepatitis B virus infection

Genetics of hepatocellular carcinoma: The next generation

MELD: the holy grail of organ allocation?

Volume 64, Issue 6, Pages (June 2016)

Partial hepatectomy vs

Presentation transcript:

Volume 61, Issue 1, Pages 82-88 (July 2014) Partial hepatectomy vs. transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond Milan criteria: A RCT Lei Yin, Hui Li, Ai-Jun Li, Wan Yee Lau, Ze-ya Pan, Eric C.H. Lai, Meng-chao Wu, Wei-Ping Zhou Journal of Hepatology Volume 61, Issue 1, Pages 82-88 (July 2014) DOI: 10.1016/j.jhep.2014.03.012 Copyright © 2014 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Flow diagram. Journal of Hepatology 2014 61, 82-88DOI: (10.1016/j.jhep.2014.03.012) Copyright © 2014 European Association for the Study of the Liver Terms and Conditions

Fig. 2 Overall survival curves for PH and TACE. Journal of Hepatology 2014 61, 82-88DOI: (10.1016/j.jhep.2014.03.012) Copyright © 2014 European Association for the Study of the Liver Terms and Conditions

Fig. 3 Overall survival curves for patients with 2 tumors after PH or TACE. Journal of Hepatology 2014 61, 82-88DOI: (10.1016/j.jhep.2014.03.012) Copyright © 2014 European Association for the Study of the Liver Terms and Conditions

Fig. 4 Overall survival curves for patients with >2 tumors after PH or TACE. Journal of Hepatology 2014 61, 82-88DOI: (10.1016/j.jhep.2014.03.012) Copyright © 2014 European Association for the Study of the Liver Terms and Conditions